Moreover, miR‐150 could suppress HCC cell invasion and metastasis by targeting ZEB1, matrix metallopeptidase 14 (MMP14), and matrix metallopeptidase 16 (MMP16). The gene discussed is MMP16; the disease is hepatocellular carcinoma.